nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—Topoisomerase Inhibitors—Topotecan—ovarian cancer	0.229	0.531	CiPCiCtD
Mitoxantrone—breast cancer—ovarian cancer	0.21	1	CtDrD
Mitoxantrone—Topoisomerase Inhibitors—Epirubicin—ovarian cancer	0.105	0.244	CiPCiCtD
Mitoxantrone—CYP1B1—ovarian cancer	0.101	0.777	CbGaD
Mitoxantrone—Topoisomerase Inhibitors—Doxorubicin—ovarian cancer	0.0972	0.225	CiPCiCtD
Mitoxantrone—ABCB1—ovarian cancer	0.0289	0.223	CbGaD
Mitoxantrone—TOP2A—Epirubicin—ovarian cancer	0.0177	0.122	CbGbCtD
Mitoxantrone—CYP1B1—Paclitaxel—ovarian cancer	0.0136	0.0941	CbGbCtD
Mitoxantrone—ABCG2—Topotecan—ovarian cancer	0.0131	0.0903	CbGbCtD
Mitoxantrone—CYP1B1—Docetaxel—ovarian cancer	0.00985	0.068	CbGbCtD
Mitoxantrone—ABCC1—Epirubicin—ovarian cancer	0.00981	0.0678	CbGbCtD
Mitoxantrone—ABCC1—Paclitaxel—ovarian cancer	0.00968	0.0668	CbGbCtD
Mitoxantrone—TOP2A—Doxorubicin—ovarian cancer	0.00941	0.065	CbGbCtD
Mitoxantrone—CYP1B1—Doxorubicin—ovarian cancer	0.00734	0.0507	CbGbCtD
Mitoxantrone—ABCC1—Docetaxel—ovarian cancer	0.007	0.0483	CbGbCtD
Mitoxantrone—ABCG2—Paclitaxel—ovarian cancer	0.00648	0.0447	CbGbCtD
Mitoxantrone—ABCG2—Carboplatin—ovarian cancer	0.00609	0.0421	CbGbCtD
Mitoxantrone—ABCC1—Doxorubicin—ovarian cancer	0.00522	0.036	CbGbCtD
Mitoxantrone—ABCB1—Topotecan—ovarian cancer	0.00472	0.0326	CbGbCtD
Mitoxantrone—ABCG2—Docetaxel—ovarian cancer	0.00468	0.0323	CbGbCtD
Mitoxantrone—ABCG2—Doxorubicin—ovarian cancer	0.00349	0.0241	CbGbCtD
Mitoxantrone—ABCB1—Vinorelbine—ovarian cancer	0.00332	0.023	CbGbCtD
Mitoxantrone—CYP3A4—Topotecan—ovarian cancer	0.00283	0.0195	CbGbCtD
Mitoxantrone—ABCB1—Paclitaxel—ovarian cancer	0.00234	0.0161	CbGbCtD
Mitoxantrone—CYP3A4—Vinorelbine—ovarian cancer	0.00199	0.0138	CbGbCtD
Mitoxantrone—ABCB1—Docetaxel—ovarian cancer	0.00169	0.0117	CbGbCtD
Mitoxantrone—CYP3A4—Paclitaxel—ovarian cancer	0.0014	0.00966	CbGbCtD
Mitoxantrone—ABCB1—Doxorubicin—ovarian cancer	0.00126	0.00869	CbGbCtD
Mitoxantrone—CYP3A4—Docetaxel—ovarian cancer	0.00101	0.00699	CbGbCtD
Mitoxantrone—CYP3A4—Doxorubicin—ovarian cancer	0.000754	0.00521	CbGbCtD
Mitoxantrone—BTK—myometrium—ovarian cancer	0.000731	0.0427	CbGeAlD
Mitoxantrone—PIM1—myometrium—ovarian cancer	0.000633	0.0369	CbGeAlD
Mitoxantrone—BTK—decidua—ovarian cancer	0.000542	0.0316	CbGeAlD
Mitoxantrone—SLC47A2—vagina—ovarian cancer	0.000511	0.0298	CbGeAlD
Mitoxantrone—PIM1—uterine cervix—ovarian cancer	0.000493	0.0288	CbGeAlD
Mitoxantrone—PIM1—decidua—ovarian cancer	0.000469	0.0274	CbGeAlD
Mitoxantrone—PIM1—endometrium—ovarian cancer	0.000446	0.026	CbGeAlD
Mitoxantrone—PIM1—uterus—ovarian cancer	0.000411	0.024	CbGeAlD
Mitoxantrone—BTK—bone marrow—ovarian cancer	0.000402	0.0235	CbGeAlD
Mitoxantrone—BTK—female gonad—ovarian cancer	0.000388	0.0226	CbGeAlD
Mitoxantrone—BTK—vagina—ovarian cancer	0.000385	0.0225	CbGeAlD
Mitoxantrone—TOP2A—myometrium—ovarian cancer	0.000371	0.0217	CbGeAlD
Mitoxantrone—PIM1—female reproductive system—ovarian cancer	0.000369	0.0215	CbGeAlD
Mitoxantrone—PIM1—bone marrow—ovarian cancer	0.000348	0.0203	CbGeAlD
Mitoxantrone—BTK—testis—ovarian cancer	0.000344	0.0201	CbGeAlD
Mitoxantrone—SLC47A1—myometrium—ovarian cancer	0.000339	0.0198	CbGeAlD
Mitoxantrone—PIM1—female gonad—ovarian cancer	0.000336	0.0196	CbGeAlD
Mitoxantrone—PIM1—vagina—ovarian cancer	0.000334	0.0195	CbGeAlD
Mitoxantrone—PIM1—testis—ovarian cancer	0.000298	0.0174	CbGeAlD
Mitoxantrone—TOP2A—uterine cervix—ovarian cancer	0.000289	0.0169	CbGeAlD
Mitoxantrone—TOP2A—decidua—ovarian cancer	0.000275	0.0161	CbGeAlD
Mitoxantrone—SLC47A1—uterine cervix—ovarian cancer	0.000264	0.0154	CbGeAlD
Mitoxantrone—TOP2A—endometrium—ovarian cancer	0.000261	0.0153	CbGeAlD
Mitoxantrone—SLC47A1—decidua—ovarian cancer	0.000251	0.0147	CbGeAlD
Mitoxantrone—BTK—lymph node—ovarian cancer	0.000249	0.0145	CbGeAlD
Mitoxantrone—TOP2A—uterus—ovarian cancer	0.000241	0.0141	CbGeAlD
Mitoxantrone—SLC47A1—endometrium—ovarian cancer	0.000239	0.0139	CbGeAlD
Mitoxantrone—ABCC1—myometrium—ovarian cancer	0.000224	0.0131	CbGeAlD
Mitoxantrone—SLC47A1—gonad—ovarian cancer	0.000221	0.0129	CbGeAlD
Mitoxantrone—SLC47A1—uterus—ovarian cancer	0.00022	0.0128	CbGeAlD
Mitoxantrone—PIM1—lymph node—ovarian cancer	0.000216	0.0126	CbGeAlD
Mitoxantrone—TOP2A—Docetaxel—Paclitaxel—ovarian cancer	0.000208	0.219	CbGdCrCtD
Mitoxantrone—TOP2A—bone marrow—ovarian cancer	0.000204	0.0119	CbGeAlD
Mitoxantrone—SLC47A1—female reproductive system—ovarian cancer	0.000198	0.0115	CbGeAlD
Mitoxantrone—TOP2A—female gonad—ovarian cancer	0.000197	0.0115	CbGeAlD
Mitoxantrone—TOP2A—vagina—ovarian cancer	0.000196	0.0114	CbGeAlD
Mitoxantrone—ABCG2—myometrium—ovarian cancer	0.000185	0.0108	CbGeAlD
Mitoxantrone—CYP1B1—decidua—ovarian cancer	0.000184	0.0108	CbGeAlD
Mitoxantrone—SLC47A1—female gonad—ovarian cancer	0.00018	0.0105	CbGeAlD
Mitoxantrone—SLC47A1—vagina—ovarian cancer	0.000179	0.0104	CbGeAlD
Mitoxantrone—TOP2A—Irinotecan—Topotecan—ovarian cancer	0.000178	0.187	CbGdCrCtD
Mitoxantrone—TOP2A—testis—ovarian cancer	0.000175	0.0102	CbGeAlD
Mitoxantrone—ABCC1—uterine cervix—ovarian cancer	0.000174	0.0102	CbGeAlD
Mitoxantrone—ABCC1—decidua—ovarian cancer	0.000166	0.00968	CbGeAlD
Mitoxantrone—CYP1B1—gonad—ovarian cancer	0.000162	0.00947	CbGeAlD
Mitoxantrone—CYP1B1—uterus—ovarian cancer	0.000161	0.00941	CbGeAlD
Mitoxantrone—SLC47A1—testis—ovarian cancer	0.00016	0.00932	CbGeAlD
Mitoxantrone—ABCC1—endometrium—ovarian cancer	0.000157	0.00919	CbGeAlD
Mitoxantrone—ABCC1—uterus—ovarian cancer	0.000145	0.00847	CbGeAlD
Mitoxantrone—CYP1B1—female reproductive system—ovarian cancer	0.000145	0.00846	CbGeAlD
Mitoxantrone—ABCG2—uterine cervix—ovarian cancer	0.000144	0.00841	CbGeAlD
Mitoxantrone—ABCG2—decidua—ovarian cancer	0.000137	0.00801	CbGeAlD
Mitoxantrone—TOP2A—Vindesine—Vinorelbine—ovarian cancer	0.000132	0.139	CbGdCrCtD
Mitoxantrone—CYP1B1—female gonad—ovarian cancer	0.000132	0.0077	CbGeAlD
Mitoxantrone—ABCG2—endometrium—ovarian cancer	0.00013	0.00761	CbGeAlD
Mitoxantrone—TOP2A—lymph node—ovarian cancer	0.000127	0.00739	CbGeAlD
Mitoxantrone—ABCG2—uterus—ovarian cancer	0.00012	0.00701	CbGeAlD
Mitoxantrone—ABCC1—female gonad—ovarian cancer	0.000119	0.00692	CbGeAlD
Mitoxantrone—ABCC1—vagina—ovarian cancer	0.000118	0.00688	CbGeAlD
Mitoxantrone—CYP1B1—testis—ovarian cancer	0.000117	0.00683	CbGeAlD
Mitoxantrone—SLC47A1—lymph node—ovarian cancer	0.000116	0.00675	CbGeAlD
Mitoxantrone—ABCC1—testis—ovarian cancer	0.000105	0.00614	CbGeAlD
Mitoxantrone—TOP2A—Paclitaxel—Docetaxel—ovarian cancer	0.000104	0.109	CbGdCrCtD
Mitoxantrone—ABCG2—bone marrow—ovarian cancer	0.000102	0.00595	CbGeAlD
Mitoxantrone—ABCG2—female gonad—ovarian cancer	9.82e-05	0.00573	CbGeAlD
Mitoxantrone—ABCG2—vagina—ovarian cancer	9.76e-05	0.0057	CbGeAlD
Mitoxantrone—CYP2E1—female reproductive system—ovarian cancer	9.34e-05	0.00545	CbGeAlD
Mitoxantrone—ABCB1—myometrium—ovarian cancer	9.13e-05	0.00533	CbGeAlD
Mitoxantrone—ABCB1—embryo—ovarian cancer	8.78e-05	0.00513	CbGeAlD
Mitoxantrone—ABCG2—testis—ovarian cancer	8.71e-05	0.00508	CbGeAlD
Mitoxantrone—CYP1B1—lymph node—ovarian cancer	8.48e-05	0.00495	CbGeAlD
Mitoxantrone—ABCC1—lymph node—ovarian cancer	7.63e-05	0.00445	CbGeAlD
Mitoxantrone—CYP2E1—testis—ovarian cancer	7.54e-05	0.0044	CbGeAlD
Mitoxantrone—CYP3A4—female reproductive system—ovarian cancer	7.52e-05	0.00439	CbGeAlD
Mitoxantrone—ABCB1—epithelium—ovarian cancer	7.16e-05	0.00418	CbGeAlD
Mitoxantrone—TOP2A—Vincristine—Vinorelbine—ovarian cancer	7.15e-05	0.075	CbGdCrCtD
Mitoxantrone—ABCB1—uterine cervix—ovarian cancer	7.1e-05	0.00415	CbGeAlD
Mitoxantrone—ABCB1—decidua—ovarian cancer	6.77e-05	0.00395	CbGeAlD
Mitoxantrone—ABCB1—endometrium—ovarian cancer	6.42e-05	0.00375	CbGeAlD
Mitoxantrone—ABCG2—lymph node—ovarian cancer	6.31e-05	0.00369	CbGeAlD
Mitoxantrone—ABCB1—gonad—ovarian cancer	5.96e-05	0.00348	CbGeAlD
Mitoxantrone—ABCB1—uterus—ovarian cancer	5.92e-05	0.00346	CbGeAlD
Mitoxantrone—TOP2A—Vinblastine—Vinorelbine—ovarian cancer	5.75e-05	0.0603	CbGdCrCtD
Mitoxantrone—ABCB1—female reproductive system—ovarian cancer	5.32e-05	0.00311	CbGeAlD
Mitoxantrone—ABCB1—bone marrow—ovarian cancer	5.02e-05	0.00293	CbGeAlD
Mitoxantrone—ABCB1—female gonad—ovarian cancer	4.84e-05	0.00283	CbGeAlD
Mitoxantrone—ABCB1—vagina—ovarian cancer	4.81e-05	0.00281	CbGeAlD
Mitoxantrone—ABCB1—testis—ovarian cancer	4.3e-05	0.00251	CbGeAlD
Mitoxantrone—TOP2A—Daunorubicin—Epirubicin—ovarian cancer	3.48e-05	0.0365	CbGdCrCtD
Mitoxantrone—TOP2A—Idarubicin—Epirubicin—ovarian cancer	3.48e-05	0.0365	CbGdCrCtD
Mitoxantrone—TOP2A—Doxorubicin—Epirubicin—ovarian cancer	3.48e-05	0.0365	CbGdCrCtD
Mitoxantrone—TOP2A—Epirubicin—Doxorubicin—ovarian cancer	3.22e-05	0.0338	CbGdCrCtD
Mitoxantrone—TOP2A—Idarubicin—Doxorubicin—ovarian cancer	3.22e-05	0.0338	CbGdCrCtD
Mitoxantrone—TOP2A—Daunorubicin—Doxorubicin—ovarian cancer	3.22e-05	0.0338	CbGdCrCtD
Mitoxantrone—ABCB1—lymph node—ovarian cancer	3.11e-05	0.00182	CbGeAlD
Mitoxantrone—Convulsion—Paclitaxel—ovarian cancer	2.68e-05	0.000563	CcSEcCtD
Mitoxantrone—Hypokalaemia—Epirubicin—ovarian cancer	2.67e-05	0.000562	CcSEcCtD
Mitoxantrone—Hypertension—Paclitaxel—ovarian cancer	2.67e-05	0.000561	CcSEcCtD
Mitoxantrone—Alopecia—Docetaxel—ovarian cancer	2.66e-05	0.000559	CcSEcCtD
Mitoxantrone—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	2.64e-05	0.000556	CcSEcCtD
Mitoxantrone—Chest pain—Paclitaxel—ovarian cancer	2.63e-05	0.000553	CcSEcCtD
Mitoxantrone—Arthralgia—Paclitaxel—ovarian cancer	2.63e-05	0.000553	CcSEcCtD
Mitoxantrone—Myalgia—Paclitaxel—ovarian cancer	2.63e-05	0.000553	CcSEcCtD
Mitoxantrone—Anxiety—Paclitaxel—ovarian cancer	2.62e-05	0.000552	CcSEcCtD
Mitoxantrone—Erythema—Docetaxel—ovarian cancer	2.62e-05	0.000551	CcSEcCtD
Mitoxantrone—Nausea—Topotecan—ovarian cancer	2.6e-05	0.000548	CcSEcCtD
Mitoxantrone—Discomfort—Paclitaxel—ovarian cancer	2.6e-05	0.000547	CcSEcCtD
Mitoxantrone—Alanine aminotransferase increased—Epirubicin—ovarian cancer	2.59e-05	0.000544	CcSEcCtD
Mitoxantrone—Diarrhoea—Vinorelbine—ovarian cancer	2.56e-05	0.00054	CcSEcCtD
Mitoxantrone—Dysgeusia—Docetaxel—ovarian cancer	2.56e-05	0.00054	CcSEcCtD
Mitoxantrone—Nausea—Melphalan—ovarian cancer	2.55e-05	0.000536	CcSEcCtD
Mitoxantrone—Confusional state—Paclitaxel—ovarian cancer	2.54e-05	0.000535	CcSEcCtD
Mitoxantrone—Blood creatinine increased—Doxorubicin—ovarian cancer	2.54e-05	0.000535	CcSEcCtD
Mitoxantrone—Back pain—Docetaxel—ovarian cancer	2.53e-05	0.000533	CcSEcCtD
Mitoxantrone—Dehydration—Doxorubicin—ovarian cancer	2.52e-05	0.000531	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Paclitaxel—ovarian cancer	2.52e-05	0.000531	CcSEcCtD
Mitoxantrone—Oedema—Paclitaxel—ovarian cancer	2.52e-05	0.000531	CcSEcCtD
Mitoxantrone—Infection—Paclitaxel—ovarian cancer	2.5e-05	0.000527	CcSEcCtD
Mitoxantrone—Shock—Paclitaxel—ovarian cancer	2.48e-05	0.000522	CcSEcCtD
Mitoxantrone—Abdominal pain upper—Doxorubicin—ovarian cancer	2.48e-05	0.000522	CcSEcCtD
Mitoxantrone—Hypokalaemia—Doxorubicin—ovarian cancer	2.47e-05	0.00052	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Paclitaxel—ovarian cancer	2.47e-05	0.000519	CcSEcCtD
Mitoxantrone—Tachycardia—Paclitaxel—ovarian cancer	2.46e-05	0.000518	CcSEcCtD
Mitoxantrone—Skin disorder—Paclitaxel—ovarian cancer	2.45e-05	0.000515	CcSEcCtD
Mitoxantrone—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	2.44e-05	0.000514	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Paclitaxel—ovarian cancer	2.44e-05	0.000513	CcSEcCtD
Mitoxantrone—Anaemia—Docetaxel—ovarian cancer	2.42e-05	0.000509	CcSEcCtD
Mitoxantrone—Pancytopenia—Epirubicin—ovarian cancer	2.41e-05	0.000507	CcSEcCtD
Mitoxantrone—Anorexia—Paclitaxel—ovarian cancer	2.4e-05	0.000506	CcSEcCtD
Mitoxantrone—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	2.39e-05	0.000504	CcSEcCtD
Mitoxantrone—Vomiting—Vinorelbine—ovarian cancer	2.38e-05	0.000502	CcSEcCtD
Mitoxantrone—Neutropenia—Epirubicin—ovarian cancer	2.37e-05	0.000499	CcSEcCtD
Mitoxantrone—Rash—Vinorelbine—ovarian cancer	2.36e-05	0.000497	CcSEcCtD
Mitoxantrone—Dermatitis—Vinorelbine—ovarian cancer	2.36e-05	0.000497	CcSEcCtD
Mitoxantrone—Hypotension—Paclitaxel—ovarian cancer	2.36e-05	0.000496	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Epirubicin—ovarian cancer	2.36e-05	0.000496	CcSEcCtD
Mitoxantrone—Headache—Vinorelbine—ovarian cancer	2.35e-05	0.000494	CcSEcCtD
Mitoxantrone—Leukopenia—Docetaxel—ovarian cancer	2.34e-05	0.000493	CcSEcCtD
Mitoxantrone—Weight increased—Epirubicin—ovarian cancer	2.31e-05	0.000485	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	2.3e-05	0.000483	CcSEcCtD
Mitoxantrone—Weight decreased—Epirubicin—ovarian cancer	2.29e-05	0.000483	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Epirubicin—ovarian cancer	2.29e-05	0.000481	CcSEcCtD
Mitoxantrone—Cough—Docetaxel—ovarian cancer	2.28e-05	0.000481	CcSEcCtD
Mitoxantrone—Pneumonia—Epirubicin—ovarian cancer	2.27e-05	0.000478	CcSEcCtD
Mitoxantrone—Convulsion—Docetaxel—ovarian cancer	2.27e-05	0.000477	CcSEcCtD
Mitoxantrone—Paraesthesia—Paclitaxel—ovarian cancer	2.26e-05	0.000476	CcSEcCtD
Mitoxantrone—Hypertension—Docetaxel—ovarian cancer	2.26e-05	0.000476	CcSEcCtD
Mitoxantrone—Drowsiness—Epirubicin—ovarian cancer	2.26e-05	0.000476	CcSEcCtD
Mitoxantrone—Dyspnoea—Paclitaxel—ovarian cancer	2.25e-05	0.000473	CcSEcCtD
Mitoxantrone—Somnolence—Paclitaxel—ovarian cancer	2.24e-05	0.000472	CcSEcCtD
Mitoxantrone—Arthralgia—Docetaxel—ovarian cancer	2.23e-05	0.000469	CcSEcCtD
Mitoxantrone—Chest pain—Docetaxel—ovarian cancer	2.23e-05	0.000469	CcSEcCtD
Mitoxantrone—Myalgia—Docetaxel—ovarian cancer	2.23e-05	0.000469	CcSEcCtD
Mitoxantrone—Pancytopenia—Doxorubicin—ovarian cancer	2.23e-05	0.000469	CcSEcCtD
Mitoxantrone—Nausea—Vinorelbine—ovarian cancer	2.23e-05	0.000469	CcSEcCtD
Mitoxantrone—Renal failure—Epirubicin—ovarian cancer	2.22e-05	0.000468	CcSEcCtD
Mitoxantrone—Dyspepsia—Paclitaxel—ovarian cancer	2.22e-05	0.000467	CcSEcCtD
Mitoxantrone—Stomatitis—Epirubicin—ovarian cancer	2.2e-05	0.000464	CcSEcCtD
Mitoxantrone—Jaundice—Epirubicin—ovarian cancer	2.2e-05	0.000464	CcSEcCtD
Mitoxantrone—Conjunctivitis—Epirubicin—ovarian cancer	2.2e-05	0.000462	CcSEcCtD
Mitoxantrone—Urinary tract infection—Epirubicin—ovarian cancer	2.2e-05	0.000462	CcSEcCtD
Mitoxantrone—Neutropenia—Doxorubicin—ovarian cancer	2.19e-05	0.000462	CcSEcCtD
Mitoxantrone—Decreased appetite—Paclitaxel—ovarian cancer	2.19e-05	0.000461	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Doxorubicin—ovarian cancer	2.18e-05	0.000459	CcSEcCtD
Mitoxantrone—Fatigue—Paclitaxel—ovarian cancer	2.17e-05	0.000457	CcSEcCtD
Mitoxantrone—Sweating—Epirubicin—ovarian cancer	2.17e-05	0.000456	CcSEcCtD
Mitoxantrone—Pain—Paclitaxel—ovarian cancer	2.16e-05	0.000454	CcSEcCtD
Mitoxantrone—Constipation—Paclitaxel—ovarian cancer	2.16e-05	0.000454	CcSEcCtD
Mitoxantrone—Haematuria—Epirubicin—ovarian cancer	2.15e-05	0.000453	CcSEcCtD
Mitoxantrone—Confusional state—Docetaxel—ovarian cancer	2.15e-05	0.000453	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Docetaxel—ovarian cancer	2.14e-05	0.00045	CcSEcCtD
Mitoxantrone—Oedema—Docetaxel—ovarian cancer	2.14e-05	0.00045	CcSEcCtD
Mitoxantrone—Weight increased—Doxorubicin—ovarian cancer	2.13e-05	0.000449	CcSEcCtD
Mitoxantrone—Infection—Docetaxel—ovarian cancer	2.12e-05	0.000447	CcSEcCtD
Mitoxantrone—Weight decreased—Doxorubicin—ovarian cancer	2.12e-05	0.000447	CcSEcCtD
Mitoxantrone—Sinusitis—Epirubicin—ovarian cancer	2.12e-05	0.000446	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Doxorubicin—ovarian cancer	2.12e-05	0.000445	CcSEcCtD
Mitoxantrone—Agranulocytosis—Epirubicin—ovarian cancer	2.11e-05	0.000444	CcSEcCtD
Mitoxantrone—Pneumonia—Doxorubicin—ovarian cancer	2.1e-05	0.000443	CcSEcCtD
Mitoxantrone—Shock—Docetaxel—ovarian cancer	2.1e-05	0.000442	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Docetaxel—ovarian cancer	2.09e-05	0.00044	CcSEcCtD
Mitoxantrone—Drowsiness—Doxorubicin—ovarian cancer	2.09e-05	0.00044	CcSEcCtD
Mitoxantrone—Tachycardia—Docetaxel—ovarian cancer	2.09e-05	0.000439	CcSEcCtD
Mitoxantrone—Feeling abnormal—Paclitaxel—ovarian cancer	2.08e-05	0.000437	CcSEcCtD
Mitoxantrone—Skin disorder—Docetaxel—ovarian cancer	2.08e-05	0.000437	CcSEcCtD
Mitoxantrone—Bradycardia—Epirubicin—ovarian cancer	2.07e-05	0.000435	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Paclitaxel—ovarian cancer	2.06e-05	0.000434	CcSEcCtD
Mitoxantrone—Renal failure—Doxorubicin—ovarian cancer	2.06e-05	0.000433	CcSEcCtD
Mitoxantrone—Haemoglobin—Epirubicin—ovarian cancer	2.04e-05	0.000429	CcSEcCtD
Mitoxantrone—Stomatitis—Doxorubicin—ovarian cancer	2.04e-05	0.000429	CcSEcCtD
Mitoxantrone—Jaundice—Doxorubicin—ovarian cancer	2.04e-05	0.000429	CcSEcCtD
Mitoxantrone—Anorexia—Docetaxel—ovarian cancer	2.04e-05	0.000429	CcSEcCtD
Mitoxantrone—Rhinitis—Epirubicin—ovarian cancer	2.03e-05	0.000428	CcSEcCtD
Mitoxantrone—Conjunctivitis—Doxorubicin—ovarian cancer	2.03e-05	0.000428	CcSEcCtD
Mitoxantrone—Urinary tract infection—Doxorubicin—ovarian cancer	2.03e-05	0.000428	CcSEcCtD
Mitoxantrone—Hepatitis—Epirubicin—ovarian cancer	2.03e-05	0.000427	CcSEcCtD
Mitoxantrone—Haemorrhage—Epirubicin—ovarian cancer	2.03e-05	0.000427	CcSEcCtD
Mitoxantrone—Pharyngitis—Epirubicin—ovarian cancer	2.01e-05	0.000424	CcSEcCtD
Mitoxantrone—Sweating—Doxorubicin—ovarian cancer	2e-05	0.000422	CcSEcCtD
Mitoxantrone—Urticaria—Paclitaxel—ovarian cancer	2e-05	0.000422	CcSEcCtD
Mitoxantrone—Hypotension—Docetaxel—ovarian cancer	2e-05	0.00042	CcSEcCtD
Mitoxantrone—Haematuria—Doxorubicin—ovarian cancer	1.99e-05	0.00042	CcSEcCtD
Mitoxantrone—Body temperature increased—Paclitaxel—ovarian cancer	1.99e-05	0.000419	CcSEcCtD
Mitoxantrone—Abdominal pain—Paclitaxel—ovarian cancer	1.99e-05	0.000419	CcSEcCtD
Mitoxantrone—Sinusitis—Doxorubicin—ovarian cancer	1.96e-05	0.000413	CcSEcCtD
Mitoxantrone—Agranulocytosis—Doxorubicin—ovarian cancer	1.95e-05	0.000411	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	1.95e-05	0.00041	CcSEcCtD
Mitoxantrone—Paraesthesia—Docetaxel—ovarian cancer	1.92e-05	0.000404	CcSEcCtD
Mitoxantrone—Bradycardia—Doxorubicin—ovarian cancer	1.91e-05	0.000402	CcSEcCtD
Mitoxantrone—Dyspnoea—Docetaxel—ovarian cancer	1.91e-05	0.000401	CcSEcCtD
Mitoxantrone—Somnolence—Docetaxel—ovarian cancer	1.9e-05	0.0004	CcSEcCtD
Mitoxantrone—Haemoglobin—Doxorubicin—ovarian cancer	1.89e-05	0.000397	CcSEcCtD
Mitoxantrone—Rhinitis—Doxorubicin—ovarian cancer	1.88e-05	0.000396	CcSEcCtD
Mitoxantrone—Dyspepsia—Docetaxel—ovarian cancer	1.88e-05	0.000396	CcSEcCtD
Mitoxantrone—Hepatitis—Doxorubicin—ovarian cancer	1.88e-05	0.000395	CcSEcCtD
Mitoxantrone—Haemorrhage—Doxorubicin—ovarian cancer	1.88e-05	0.000395	CcSEcCtD
Mitoxantrone—Pharyngitis—Doxorubicin—ovarian cancer	1.86e-05	0.000392	CcSEcCtD
Mitoxantrone—Decreased appetite—Docetaxel—ovarian cancer	1.86e-05	0.000391	CcSEcCtD
Mitoxantrone—Hypersensitivity—Paclitaxel—ovarian cancer	1.86e-05	0.000391	CcSEcCtD
Mitoxantrone—Fatigue—Docetaxel—ovarian cancer	1.84e-05	0.000388	CcSEcCtD
Mitoxantrone—Pain—Docetaxel—ovarian cancer	1.83e-05	0.000385	CcSEcCtD
Mitoxantrone—Constipation—Docetaxel—ovarian cancer	1.83e-05	0.000385	CcSEcCtD
Mitoxantrone—Chills—Epirubicin—ovarian cancer	1.82e-05	0.000383	CcSEcCtD
Mitoxantrone—Arrhythmia—Epirubicin—ovarian cancer	1.81e-05	0.000381	CcSEcCtD
Mitoxantrone—Asthenia—Paclitaxel—ovarian cancer	1.81e-05	0.000381	CcSEcCtD
Mitoxantrone—Alopecia—Epirubicin—ovarian cancer	1.79e-05	0.000377	CcSEcCtD
Mitoxantrone—Erythema—Epirubicin—ovarian cancer	1.77e-05	0.000372	CcSEcCtD
Mitoxantrone—Feeling abnormal—Docetaxel—ovarian cancer	1.76e-05	0.000371	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Docetaxel—ovarian cancer	1.75e-05	0.000368	CcSEcCtD
Mitoxantrone—Dysgeusia—Epirubicin—ovarian cancer	1.73e-05	0.000364	CcSEcCtD
Mitoxantrone—Diarrhoea—Paclitaxel—ovarian cancer	1.72e-05	0.000363	CcSEcCtD
Mitoxantrone—Back pain—Epirubicin—ovarian cancer	1.71e-05	0.00036	CcSEcCtD
Mitoxantrone—Body temperature increased—Docetaxel—ovarian cancer	1.69e-05	0.000356	CcSEcCtD
Mitoxantrone—Abdominal pain—Docetaxel—ovarian cancer	1.69e-05	0.000356	CcSEcCtD
Mitoxantrone—Chills—Doxorubicin—ovarian cancer	1.68e-05	0.000354	CcSEcCtD
Mitoxantrone—Arrhythmia—Doxorubicin—ovarian cancer	1.68e-05	0.000353	CcSEcCtD
Mitoxantrone—Vision blurred—Epirubicin—ovarian cancer	1.66e-05	0.00035	CcSEcCtD
Mitoxantrone—Alopecia—Doxorubicin—ovarian cancer	1.66e-05	0.000349	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Epirubicin—ovarian cancer	1.64e-05	0.000345	CcSEcCtD
Mitoxantrone—Erythema—Doxorubicin—ovarian cancer	1.63e-05	0.000344	CcSEcCtD
Mitoxantrone—Anaemia—Epirubicin—ovarian cancer	1.63e-05	0.000344	CcSEcCtD
Mitoxantrone—Vomiting—Paclitaxel—ovarian cancer	1.6e-05	0.000337	CcSEcCtD
Mitoxantrone—Dysgeusia—Doxorubicin—ovarian cancer	1.6e-05	0.000337	CcSEcCtD
Mitoxantrone—Malaise—Epirubicin—ovarian cancer	1.59e-05	0.000335	CcSEcCtD
Mitoxantrone—Rash—Paclitaxel—ovarian cancer	1.59e-05	0.000335	CcSEcCtD
Mitoxantrone—Dermatitis—Paclitaxel—ovarian cancer	1.59e-05	0.000334	CcSEcCtD
Mitoxantrone—Leukopenia—Epirubicin—ovarian cancer	1.58e-05	0.000333	CcSEcCtD
Mitoxantrone—Back pain—Doxorubicin—ovarian cancer	1.58e-05	0.000333	CcSEcCtD
Mitoxantrone—Headache—Paclitaxel—ovarian cancer	1.58e-05	0.000332	CcSEcCtD
Mitoxantrone—Hypersensitivity—Docetaxel—ovarian cancer	1.57e-05	0.000331	CcSEcCtD
Mitoxantrone—Cough—Epirubicin—ovarian cancer	1.54e-05	0.000324	CcSEcCtD
Mitoxantrone—Vision blurred—Doxorubicin—ovarian cancer	1.54e-05	0.000324	CcSEcCtD
Mitoxantrone—Asthenia—Docetaxel—ovarian cancer	1.53e-05	0.000323	CcSEcCtD
Mitoxantrone—Convulsion—Epirubicin—ovarian cancer	1.53e-05	0.000322	CcSEcCtD
Mitoxantrone—Hypertension—Epirubicin—ovarian cancer	1.52e-05	0.000321	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Doxorubicin—ovarian cancer	1.52e-05	0.000319	CcSEcCtD
Mitoxantrone—Anaemia—Doxorubicin—ovarian cancer	1.51e-05	0.000318	CcSEcCtD
Mitoxantrone—Arthralgia—Epirubicin—ovarian cancer	1.5e-05	0.000316	CcSEcCtD
Mitoxantrone—Chest pain—Epirubicin—ovarian cancer	1.5e-05	0.000316	CcSEcCtD
Mitoxantrone—Myalgia—Epirubicin—ovarian cancer	1.5e-05	0.000316	CcSEcCtD
Mitoxantrone—Anxiety—Epirubicin—ovarian cancer	1.5e-05	0.000315	CcSEcCtD
Mitoxantrone—Nausea—Paclitaxel—ovarian cancer	1.5e-05	0.000315	CcSEcCtD
Mitoxantrone—Discomfort—Epirubicin—ovarian cancer	1.49e-05	0.000313	CcSEcCtD
Mitoxantrone—Malaise—Doxorubicin—ovarian cancer	1.47e-05	0.00031	CcSEcCtD
Mitoxantrone—Leukopenia—Doxorubicin—ovarian cancer	1.46e-05	0.000308	CcSEcCtD
Mitoxantrone—Diarrhoea—Docetaxel—ovarian cancer	1.46e-05	0.000308	CcSEcCtD
Mitoxantrone—Confusional state—Epirubicin—ovarian cancer	1.45e-05	0.000306	CcSEcCtD
Mitoxantrone—Oedema—Epirubicin—ovarian cancer	1.44e-05	0.000303	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Epirubicin—ovarian cancer	1.44e-05	0.000303	CcSEcCtD
Mitoxantrone—Infection—Epirubicin—ovarian cancer	1.43e-05	0.000301	CcSEcCtD
Mitoxantrone—Cough—Doxorubicin—ovarian cancer	1.43e-05	0.0003	CcSEcCtD
Mitoxantrone—Shock—Epirubicin—ovarian cancer	1.42e-05	0.000298	CcSEcCtD
Mitoxantrone—Convulsion—Doxorubicin—ovarian cancer	1.42e-05	0.000298	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Epirubicin—ovarian cancer	1.41e-05	0.000297	CcSEcCtD
Mitoxantrone—Hypertension—Doxorubicin—ovarian cancer	1.41e-05	0.000297	CcSEcCtD
Mitoxantrone—Tachycardia—Epirubicin—ovarian cancer	1.41e-05	0.000296	CcSEcCtD
Mitoxantrone—Skin disorder—Epirubicin—ovarian cancer	1.4e-05	0.000295	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Epirubicin—ovarian cancer	1.39e-05	0.000293	CcSEcCtD
Mitoxantrone—Arthralgia—Doxorubicin—ovarian cancer	1.39e-05	0.000293	CcSEcCtD
Mitoxantrone—Chest pain—Doxorubicin—ovarian cancer	1.39e-05	0.000293	CcSEcCtD
Mitoxantrone—Myalgia—Doxorubicin—ovarian cancer	1.39e-05	0.000293	CcSEcCtD
Mitoxantrone—Anxiety—Doxorubicin—ovarian cancer	1.39e-05	0.000292	CcSEcCtD
Mitoxantrone—Discomfort—Doxorubicin—ovarian cancer	1.37e-05	0.000289	CcSEcCtD
Mitoxantrone—Anorexia—Epirubicin—ovarian cancer	1.37e-05	0.000289	CcSEcCtD
Mitoxantrone—Vomiting—Docetaxel—ovarian cancer	1.36e-05	0.000286	CcSEcCtD
Mitoxantrone—Rash—Docetaxel—ovarian cancer	1.35e-05	0.000284	CcSEcCtD
Mitoxantrone—Hypotension—Epirubicin—ovarian cancer	1.35e-05	0.000283	CcSEcCtD
Mitoxantrone—Dermatitis—Docetaxel—ovarian cancer	1.35e-05	0.000283	CcSEcCtD
Mitoxantrone—Confusional state—Doxorubicin—ovarian cancer	1.34e-05	0.000283	CcSEcCtD
Mitoxantrone—Headache—Docetaxel—ovarian cancer	1.34e-05	0.000282	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Doxorubicin—ovarian cancer	1.33e-05	0.000281	CcSEcCtD
Mitoxantrone—Oedema—Doxorubicin—ovarian cancer	1.33e-05	0.000281	CcSEcCtD
Mitoxantrone—Infection—Doxorubicin—ovarian cancer	1.32e-05	0.000279	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	1.31e-05	0.000276	CcSEcCtD
Mitoxantrone—Shock—Doxorubicin—ovarian cancer	1.31e-05	0.000276	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Doxorubicin—ovarian cancer	1.31e-05	0.000275	CcSEcCtD
Mitoxantrone—Tachycardia—Doxorubicin—ovarian cancer	1.3e-05	0.000274	CcSEcCtD
Mitoxantrone—Skin disorder—Doxorubicin—ovarian cancer	1.3e-05	0.000273	CcSEcCtD
Mitoxantrone—Paraesthesia—Epirubicin—ovarian cancer	1.29e-05	0.000272	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Doxorubicin—ovarian cancer	1.29e-05	0.000271	CcSEcCtD
Mitoxantrone—Dyspnoea—Epirubicin—ovarian cancer	1.29e-05	0.00027	CcSEcCtD
Mitoxantrone—Somnolence—Epirubicin—ovarian cancer	1.28e-05	0.00027	CcSEcCtD
Mitoxantrone—Anorexia—Doxorubicin—ovarian cancer	1.27e-05	0.000268	CcSEcCtD
Mitoxantrone—Nausea—Docetaxel—ovarian cancer	1.27e-05	0.000267	CcSEcCtD
Mitoxantrone—Dyspepsia—Epirubicin—ovarian cancer	1.27e-05	0.000267	CcSEcCtD
Mitoxantrone—Decreased appetite—Epirubicin—ovarian cancer	1.25e-05	0.000264	CcSEcCtD
Mitoxantrone—Hypotension—Doxorubicin—ovarian cancer	1.25e-05	0.000262	CcSEcCtD
Mitoxantrone—Fatigue—Epirubicin—ovarian cancer	1.24e-05	0.000262	CcSEcCtD
Mitoxantrone—Pain—Epirubicin—ovarian cancer	1.23e-05	0.000259	CcSEcCtD
Mitoxantrone—Constipation—Epirubicin—ovarian cancer	1.23e-05	0.000259	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	1.22e-05	0.000256	CcSEcCtD
Mitoxantrone—Paraesthesia—Doxorubicin—ovarian cancer	1.2e-05	0.000252	CcSEcCtD
Mitoxantrone—Dyspnoea—Doxorubicin—ovarian cancer	1.19e-05	0.00025	CcSEcCtD
Mitoxantrone—Feeling abnormal—Epirubicin—ovarian cancer	1.19e-05	0.00025	CcSEcCtD
Mitoxantrone—Somnolence—Doxorubicin—ovarian cancer	1.19e-05	0.00025	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Epirubicin—ovarian cancer	1.18e-05	0.000248	CcSEcCtD
Mitoxantrone—Dyspepsia—Doxorubicin—ovarian cancer	1.17e-05	0.000247	CcSEcCtD
Mitoxantrone—Decreased appetite—Doxorubicin—ovarian cancer	1.16e-05	0.000244	CcSEcCtD
Mitoxantrone—Fatigue—Doxorubicin—ovarian cancer	1.15e-05	0.000242	CcSEcCtD
Mitoxantrone—Urticaria—Epirubicin—ovarian cancer	1.15e-05	0.000241	CcSEcCtD
Mitoxantrone—Pain—Doxorubicin—ovarian cancer	1.14e-05	0.00024	CcSEcCtD
Mitoxantrone—Constipation—Doxorubicin—ovarian cancer	1.14e-05	0.00024	CcSEcCtD
Mitoxantrone—Abdominal pain—Epirubicin—ovarian cancer	1.14e-05	0.00024	CcSEcCtD
Mitoxantrone—Body temperature increased—Epirubicin—ovarian cancer	1.14e-05	0.00024	CcSEcCtD
Mitoxantrone—Feeling abnormal—Doxorubicin—ovarian cancer	1.1e-05	0.000231	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Doxorubicin—ovarian cancer	1.09e-05	0.00023	CcSEcCtD
Mitoxantrone—Hypersensitivity—Epirubicin—ovarian cancer	1.06e-05	0.000223	CcSEcCtD
Mitoxantrone—Urticaria—Doxorubicin—ovarian cancer	1.06e-05	0.000223	CcSEcCtD
Mitoxantrone—Body temperature increased—Doxorubicin—ovarian cancer	1.05e-05	0.000222	CcSEcCtD
Mitoxantrone—Abdominal pain—Doxorubicin—ovarian cancer	1.05e-05	0.000222	CcSEcCtD
Mitoxantrone—Asthenia—Epirubicin—ovarian cancer	1.03e-05	0.000218	CcSEcCtD
Mitoxantrone—Diarrhoea—Epirubicin—ovarian cancer	9.86e-06	0.000208	CcSEcCtD
Mitoxantrone—Hypersensitivity—Doxorubicin—ovarian cancer	9.83e-06	0.000207	CcSEcCtD
Mitoxantrone—Asthenia—Doxorubicin—ovarian cancer	9.57e-06	0.000201	CcSEcCtD
Mitoxantrone—Vomiting—Epirubicin—ovarian cancer	9.16e-06	0.000193	CcSEcCtD
Mitoxantrone—Diarrhoea—Doxorubicin—ovarian cancer	9.12e-06	0.000192	CcSEcCtD
Mitoxantrone—Rash—Epirubicin—ovarian cancer	9.09e-06	0.000191	CcSEcCtD
Mitoxantrone—Dermatitis—Epirubicin—ovarian cancer	9.08e-06	0.000191	CcSEcCtD
Mitoxantrone—Headache—Epirubicin—ovarian cancer	9.03e-06	0.00019	CcSEcCtD
Mitoxantrone—CYP2E1—Metabolism—NME2—ovarian cancer	8.87e-06	0.000454	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	8.84e-06	0.000452	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—PIK3CB—ovarian cancer	8.84e-06	0.000452	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—MTOR—ovarian cancer	8.84e-06	0.000452	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	8.77e-06	0.000448	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYTB—ovarian cancer	8.75e-06	0.000447	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—ERBB2—ovarian cancer	8.6e-06	0.00044	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	8.57e-06	0.000438	CbGpPWpGaD
Mitoxantrone—Nausea—Epirubicin—ovarian cancer	8.56e-06	0.00018	CcSEcCtD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	8.55e-06	0.000437	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—CASP3—ovarian cancer	8.54e-06	0.000437	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL2—ovarian cancer	8.53e-06	0.000436	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—PIK3CB—ovarian cancer	8.49e-06	0.000434	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—MTOR—ovarian cancer	8.49e-06	0.000434	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	8.49e-06	0.000434	CbGpPWpGaD
Mitoxantrone—Vomiting—Doxorubicin—ovarian cancer	8.48e-06	0.000178	CcSEcCtD
Mitoxantrone—Rash—Doxorubicin—ovarian cancer	8.41e-06	0.000177	CcSEcCtD
Mitoxantrone—Dermatitis—Doxorubicin—ovarian cancer	8.4e-06	0.000177	CcSEcCtD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	8.37e-06	0.000428	CbGpPWpGaD
Mitoxantrone—Headache—Doxorubicin—ovarian cancer	8.35e-06	0.000176	CcSEcCtD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	8.3e-06	0.000424	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CDKN1B—ovarian cancer	8.3e-06	0.000424	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	8.21e-06	0.00042	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	8.19e-06	0.000419	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	8.15e-06	0.000417	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	7.99e-06	0.000409	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CDKN1B—ovarian cancer	7.97e-06	0.000407	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYTB—ovarian cancer	7.96e-06	0.000407	CbGpPWpGaD
Mitoxantrone—Nausea—Doxorubicin—ovarian cancer	7.92e-06	0.000167	CcSEcCtD
Mitoxantrone—ABCC1—Metabolism—BRIP1—ovarian cancer	7.91e-06	0.000404	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PPP1CC—ovarian cancer	7.91e-06	0.000404	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—TP53—ovarian cancer	7.88e-06	0.000403	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CTNNB1—ovarian cancer	7.84e-06	0.000401	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	7.72e-06	0.000395	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—BRIP1—ovarian cancer	7.65e-06	0.000391	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PPP1CC—ovarian cancer	7.65e-06	0.000391	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—PTEN—ovarian cancer	7.64e-06	0.000391	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—PTEN—ovarian cancer	7.34e-06	0.000375	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TLR4—ovarian cancer	7.29e-06	0.000373	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	7.25e-06	0.000371	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—IL6—ovarian cancer	7.21e-06	0.000369	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HDAC6—ovarian cancer	7.16e-06	0.000366	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6ST—ovarian cancer	6.99e-06	0.000358	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—BRIP1—ovarian cancer	6.96e-06	0.000356	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PPP1CC—ovarian cancer	6.96e-06	0.000356	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	6.93e-06	0.000354	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	6.93e-06	0.000354	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—NRAS—ovarian cancer	6.82e-06	0.000348	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	6.75e-06	0.000345	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NME2—ovarian cancer	6.68e-06	0.000342	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	6.66e-06	0.00034	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—NRAS—ovarian cancer	6.54e-06	0.000335	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—MAPK3—ovarian cancer	6.53e-06	0.000334	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	6.48e-06	0.000331	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	6.33e-06	0.000324	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	6.32e-06	0.000323	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—MAPK1—ovarian cancer	6.21e-06	0.000318	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—EGFR—ovarian cancer	6.21e-06	0.000317	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—XIAP—ovarian cancer	6.21e-06	0.000317	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CDH1—ovarian cancer	6.18e-06	0.000316	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	6.09e-06	0.000312	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SMARCA4—ovarian cancer	6.05e-06	0.000309	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CCND1—ovarian cancer	6.03e-06	0.000308	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	5.98e-06	0.000306	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—EGFR—ovarian cancer	5.96e-06	0.000305	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PIK3CD—ovarian cancer	5.91e-06	0.000302	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EREG—ovarian cancer	5.9e-06	0.000302	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—KRAS—ovarian cancer	5.87e-06	0.0003	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.76e-06	0.000295	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYTB—ovarian cancer	5.72e-06	0.000292	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDKN1B—ovarian cancer	5.65e-06	0.000289	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—KRAS—ovarian cancer	5.63e-06	0.000288	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.58e-06	0.000285	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CCND1—ovarian cancer	5.39e-06	0.000276	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—PIK3CA—ovarian cancer	5.39e-06	0.000276	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	5.34e-06	0.000273	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—YAP1—ovarian cancer	5.31e-06	0.000271	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.25e-06	0.000268	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ERBB2—ovarian cancer	5.22e-06	0.000267	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—PIK3CA—ovarian cancer	5.17e-06	0.000265	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FASN—ovarian cancer	5.16e-06	0.000264	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—MTOR—ovarian cancer	5.15e-06	0.000263	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PIK3CB—ovarian cancer	5.15e-06	0.000263	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PARP1—ovarian cancer	5.14e-06	0.000263	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—YAP1—ovarian cancer	5.13e-06	0.000262	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.08e-06	0.00026	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—BRIP1—ovarian cancer	5e-06	0.000255	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPP1CC—ovarian cancer	5e-06	0.000255	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—HRAS—ovarian cancer	4.99e-06	0.000255	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	4.98e-06	0.000254	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SLC2A1—ovarian cancer	4.91e-06	0.000251	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—MYC—ovarian cancer	4.84e-06	0.000247	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CDKN1B—ovarian cancer	4.83e-06	0.000247	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—HRAS—ovarian cancer	4.79e-06	0.000245	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—IL6—ovarian cancer	4.77e-06	0.000244	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	4.73e-06	0.000242	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL2—ovarian cancer	4.73e-06	0.000242	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—YAP1—ovarian cancer	4.67e-06	0.000239	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	4.64e-06	0.000237	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.62e-06	0.000236	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CTNNB1—ovarian cancer	4.56e-06	0.000233	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.46e-06	0.000228	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PTEN—ovarian cancer	4.45e-06	0.000227	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MAPK3—ovarian cancer	4.45e-06	0.000227	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—AKT1—ovarian cancer	4.4e-06	0.000225	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MYC—ovarian cancer	4.33e-06	0.000221	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—FASN—ovarian cancer	4.32e-06	0.000221	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.32e-06	0.000221	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYTB—ovarian cancer	4.31e-06	0.00022	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	4.3e-06	0.00022	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SLC5A5—ovarian cancer	4.25e-06	0.000217	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MAPK1—ovarian cancer	4.23e-06	0.000216	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—AKT1—ovarian cancer	4.23e-06	0.000216	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	4.22e-06	0.000216	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—FASN—ovarian cancer	4.18e-06	0.000214	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.17e-06	0.000213	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PPP2R1A—ovarian cancer	4.17e-06	0.000213	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NME2—ovarian cancer	4.12e-06	0.00021	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SLC5A5—ovarian cancer	4.11e-06	0.00021	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SLC2A1—ovarian cancer	4.11e-06	0.00021	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	4.1e-06	0.00021	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	4.06e-06	0.000208	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.02e-06	0.000206	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—STAT3—ovarian cancer	3.98e-06	0.000203	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SLC2A1—ovarian cancer	3.97e-06	0.000203	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—NRAS—ovarian cancer	3.97e-06	0.000203	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	3.96e-06	0.000202	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP1B1—ovarian cancer	3.94e-06	0.000201	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.89e-06	0.000199	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—FASN—ovarian cancer	3.81e-06	0.000195	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—MAPK3—ovarian cancer	3.8e-06	0.000194	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPP1CC—ovarian cancer	3.76e-06	0.000192	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—BRIP1—ovarian cancer	3.76e-06	0.000192	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SLC5A5—ovarian cancer	3.74e-06	0.000191	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—MAPK1—ovarian cancer	3.62e-06	0.000185	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—EGFR—ovarian cancer	3.62e-06	0.000185	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SLC2A1—ovarian cancer	3.62e-06	0.000185	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	3.58e-06	0.000183	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—ovarian cancer	3.55e-06	0.000182	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PPP2R1A—ovarian cancer	3.49e-06	0.000179	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.48e-06	0.000178	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP1B1—ovarian cancer	3.47e-06	0.000177	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—KRAS—ovarian cancer	3.42e-06	0.000175	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	3.38e-06	0.000173	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PPP2R1A—ovarian cancer	3.38e-06	0.000173	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.36e-06	0.000172	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—YAP1—ovarian cancer	3.35e-06	0.000171	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TERT—ovarian cancer	3.31e-06	0.000169	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	3.29e-06	0.000168	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ABCB1—ovarian cancer	3.24e-06	0.000166	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	3.22e-06	0.000165	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	3.22e-06	0.000165	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—TYMS—ovarian cancer	3.19e-06	0.000163	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PIK3CA—ovarian cancer	3.14e-06	0.00016	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ABCB1—ovarian cancer	3.14e-06	0.00016	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—TYMS—ovarian cancer	3.08e-06	0.000158	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PPP2R1A—ovarian cancer	3.07e-06	0.000157	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CAV1—ovarian cancer	3.07e-06	0.000157	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	3.04e-06	0.000155	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6ST—ovarian cancer	2.91e-06	0.000149	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HRAS—ovarian cancer	2.9e-06	0.000148	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ABCB1—ovarian cancer	2.85e-06	0.000146	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—TYMS—ovarian cancer	2.8e-06	0.000143	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	2.79e-06	0.000143	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APC—ovarian cancer	2.79e-06	0.000143	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6—ovarian cancer	2.78e-06	0.000142	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—FASN—ovarian cancer	2.73e-06	0.00014	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	2.7e-06	0.000138	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC5A5—ovarian cancer	2.69e-06	0.000137	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYTB—ovarian cancer	2.65e-06	0.000136	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC2A1—ovarian cancer	2.6e-06	0.000133	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CAV1—ovarian cancer	2.57e-06	0.000131	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—AKT1—ovarian cancer	2.56e-06	0.000131	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—YAP1—ovarian cancer	2.52e-06	0.000129	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP1B1—ovarian cancer	2.49e-06	0.000127	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CAV1—ovarian cancer	2.48e-06	0.000127	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CD—ovarian cancer	2.45e-06	0.000125	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.45e-06	0.000125	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.37e-06	0.000121	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CG—ovarian cancer	2.34e-06	0.00012	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—BRIP1—ovarian cancer	2.32e-06	0.000119	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPP1CC—ovarian cancer	2.32e-06	0.000119	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	2.28e-06	0.000117	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CG—ovarian cancer	2.26e-06	0.000116	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CAV1—ovarian cancer	2.26e-06	0.000115	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	2.21e-06	0.000113	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ERBB2—ovarian cancer	2.17e-06	0.000111	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MTOR—ovarian cancer	2.14e-06	0.000109	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CB—ovarian cancer	2.14e-06	0.000109	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—FASN—ovarian cancer	2.06e-06	0.000105	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CG—ovarian cancer	2.06e-06	0.000105	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CD—ovarian cancer	2.06e-06	0.000105	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ABCB1—ovarian cancer	2.05e-06	0.000105	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC5A5—ovarian cancer	2.02e-06	0.000103	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TYMS—ovarian cancer	2.01e-06	0.000103	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN1B—ovarian cancer	2.01e-06	0.000103	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CD—ovarian cancer	1.99e-06	0.000102	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC2A1—ovarian cancer	1.95e-06	9.99e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CTNNB1—ovarian cancer	1.9e-06	9.7e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP1B1—ovarian cancer	1.87e-06	9.58e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTEN—ovarian cancer	1.85e-06	9.45e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CD—ovarian cancer	1.81e-06	9.25e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CB—ovarian cancer	1.79e-06	9.16e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CB—ovarian cancer	1.73e-06	8.86e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPP2R1A—ovarian cancer	1.66e-06	8.5e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—STAT3—ovarian cancer	1.65e-06	8.45e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NRAS—ovarian cancer	1.65e-06	8.43e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CAV1—ovarian cancer	1.62e-06	8.29e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAPK3—ovarian cancer	1.58e-06	8.08e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CB—ovarian cancer	1.58e-06	8.06e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—YAP1—ovarian cancer	1.56e-06	7.95e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTEN—ovarian cancer	1.55e-06	7.92e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MYC—ovarian cancer	1.54e-06	7.85e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TYMS—ovarian cancer	1.52e-06	7.75e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAPK1—ovarian cancer	1.5e-06	7.68e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EGFR—ovarian cancer	1.5e-06	7.68e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTEN—ovarian cancer	1.5e-06	7.66e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CG—ovarian cancer	1.48e-06	7.55e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KRAS—ovarian cancer	1.42e-06	7.26e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTEN—ovarian cancer	1.36e-06	6.97e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CA—ovarian cancer	1.3e-06	6.67e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CD—ovarian cancer	1.3e-06	6.64e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—FASN—ovarian cancer	1.27e-06	6.48e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.25e-06	6.38e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CAV1—ovarian cancer	1.22e-06	6.24e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HRAS—ovarian cancer	1.21e-06	6.17e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.2e-06	6.16e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6—ovarian cancer	1.15e-06	5.9e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.15e-06	5.9e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CB—ovarian cancer	1.13e-06	5.79e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CG—ovarian cancer	1.11e-06	5.69e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CA—ovarian cancer	1.09e-06	5.58e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKT1—ovarian cancer	1.07e-06	5.45e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CA—ovarian cancer	1.06e-06	5.4e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.02e-06	5.24e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTEN—ovarian cancer	9.78e-07	5e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CD—ovarian cancer	9.78e-07	5e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CA—ovarian cancer	9.61e-07	4.91e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCB1—ovarian cancer	9.51e-07	4.86e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TYMS—ovarian cancer	9.34e-07	4.77e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AKT1—ovarian cancer	8.92e-07	4.56e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AKT1—ovarian cancer	8.63e-07	4.41e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CB—ovarian cancer	8.52e-07	4.36e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKT1—ovarian cancer	7.85e-07	4.01e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CAV1—ovarian cancer	7.52e-07	3.85e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTEN—ovarian cancer	7.37e-07	3.77e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CA—ovarian cancer	6.9e-07	3.53e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CG—ovarian cancer	6.85e-07	3.5e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CD—ovarian cancer	6.03e-07	3.08e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKT1—ovarian cancer	5.64e-07	2.88e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CB—ovarian cancer	5.25e-07	2.68e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CA—ovarian cancer	5.2e-07	2.66e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTEN—ovarian cancer	4.54e-07	2.32e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKT1—ovarian cancer	4.24e-07	2.17e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CA—ovarian cancer	3.2e-07	1.64e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKT1—ovarian cancer	2.62e-07	1.34e-05	CbGpPWpGaD
